NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 24 filers reported holding NEVRO CORP in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,736,600 | -50.9% | 1,900,000 | -50.0% | 0.00% | – |
| Q1 2023 | $3,534,000 | +105.0% | 3,800,000 | +100.0% | 0.00% | – |
| Q4 2022 | $1,724,250 | -3.1% | 1,900,000 | 0.0% | 0.00% | – |
| Q3 2022 | $1,779,000 | +1.5% | 1,900,000 | 0.0% | 0.00% | – |
| Q2 2022 | $1,752,000 | -13.9% | 1,900,000 | 0.0% | 0.00% | – |
| Q1 2022 | $2,035,000 | -2.9% | 1,900,000 | 0.0% | 0.00% | – |
| Q4 2021 | $2,096,000 | -18.0% | 1,900,000 | 0.0% | 0.00% | – |
| Q3 2021 | $2,557,000 | -22.1% | 1,900,000 | 0.0% | 0.00% | – |
| Q2 2021 | $3,282,000 | +12.4% | 1,900,000 | 0.0% | 0.00% | – |
| Q1 2021 | $2,920,000 | -44.5% | 1,900,000 | -34.5% | 0.00% | – |
| Q4 2020 | $5,258,000 | +18.1% | 2,900,000 | 0.0% | 0.00% | – |
| Q3 2020 | $4,453,000 | +13.2% | 2,900,000 | 0.0% | 0.00% | – |
| Q2 2020 | $3,934,000 | – | 2,900,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 9,000,000 | $135,324,000 | 1.71% |
| DeepCurrents Investment Group LLC | 21,930,000 | $33,750,000 | 1.16% |
| WOLVERINE ASSET MANAGEMENT LLC | 44,534,000 | $69,564,000 | 0.59% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,000,000 | $18,208,000 | 0.38% |
| Context Capital Management, LLC | 2,000 | $3,084,000 | 0.30% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $2,276,000 | 0.27% |
| Polar Asset Management Partners Inc. | 17,500,000 | $26,683,000 | 0.26% |
| CSS LLC/IL | 2,500,000 | $3,780,000 | 0.16% |
| Verition Fund Management LLC | 7,486,000 | $11,543,000 | 0.13% |
| PFM Health Sciences, LP | 2,000,000 | $3,032,000 | 0.09% |